β-Amyloid (Aβ40, Aβ42) binding to modified LDL accelerates macrophage foam cell formation

Sparks, 1997, Coronary artery disease, hypertension, ApoE and cholesterol: a link to Alzheimer's disease?, Ann. N.Y. Acad. Sci., 826, 128, 10.1111/j.1749-6632.1997.tb48466.x Markesbury, 1997, Oxidative stress hypothesis in Alzheimer's disease, Free Radic. Biol. Med., 23, 134, 10.1016/S0891-5849(96)00629-6 Jellinger, 2003, The impact of cerebrovascular lesions in Alzheimer disease—a comparative autopsy study, J. Neurol., 250, 150, 10.1007/s00415-003-0142-0 Esiri, 1999, Cerebrovascular disease and dementia in the early stages of Alzheimer's disease, Lancet, 354, 919, 10.1016/S0140-6736(99)02355-7 Casserly, 2004, Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins, Lancet, 363, 1139, 10.1016/S0140-6736(04)15900-X Ross, 1999, Atherosclerosis — an inflammatory disease, N. Engl. J. Med., 340, 115, 10.1056/NEJM199901143400207 Bhakdi, 1995, On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety, J. Exp. Med., 182, 1959, 10.1084/jem.182.6.1959 Steinberg, 1997, Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis, Circulation, 95, 1062, 10.1161/01.CIR.95.4.1062 Pappolla, 2003, Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology, Neurology, 61, 199, 10.1212/01.WNL.0000070182.02537.84 Hardy, 1991, Amyloid deposition as the central event in the aetiology of Alzheimer's disease, Trends Pharmacol. Sci., 12, 383, 10.1016/0165-6147(91)90609-V Frackowiak, 1994, Non-fibrillar β-Amyloid protein is associated with smooth muscle cells of vessel walls in Alzheimer disease, J. Neuropathol. Exp. Neurol., 53, 637, 10.1097/00005072-199411000-00011 De Meyer, 2002, Platelet phagocytosis and processing of beta-amyloid precursor protein as a mechanism of macrophage activation in atherosclerosis, Circ. Res., 90, 1197, 10.1161/01.RES.0000020017.84398.61 Stanyer, 2004, Potentiation of β-amyloid polymerisation by low-density lipoprotein enhances the peptide's vasoactivity, Biochim. Biophys. Acta, 1670, 147, 10.1016/j.bbagen.2003.11.005 Xia, 2000, Role of presinilin in γ-secretase cleavage of amyloid precursor protein, Exp. Gerontol., 35, 453, 10.1016/S0531-5565(00)00111-X McLaurin, 2000, Review: modulating factors in amyloid-beta formation, J. Struct. Biol., 130, 259, 10.1006/jsbi.2000.4289 Attems, 2004, Amyloid β peptide 1–42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology, Acta Neuropathol., 107, 283, 10.1007/s00401-004-0822-6 Yazawa, 2001, β-Amyloid peptide (Aβ42) is internalized via the G-protein-coupled receptor FPRL1 and forms fibrillar aggregates in macrophages, FASEB J., 15, 2454, 10.1096/fj.01-0251com Moore, 2002, A CD36-initiated signaling cascade mediates inflammatory effects of β-amyloid, J. Biol. Chem., 277, 47373, 10.1074/jbc.M208788200 Khoury, 2003, CD36 mediates the innate host response to β-amyloid, J. Exp. Med., 197, 1657, 10.1084/jem.20021546 Coraci, 2002, CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to β-amyloid fibrils, Am. J. Pathol., 160, 101, 10.1016/S0002-9440(10)64354-4 Bamberg, 2003, A cell surface receptor complex for fibrillar ß-amyloid mediates microglial activation, J. Neurosci., 23, 2665, 10.1523/JNEUROSCI.23-07-02665.2003 Pfeiffer, 2001, Lipopolysaccharide and ceramide docking to CD14 provokes ligand-specific receptor clustering in rafts, Eur. J. Immunol., 31, 3153, 10.1002/1521-4141(200111)31:11<3153::AID-IMMU3153>3.0.CO;2-0 Laporte, 2004, Uptake of A(beta) 1–40- and A(beta) 1–42-coated yeast by microglial cells: a role for LRP, J. Leukoc. Biol., 76, 451, 10.1189/jlb.1203620 Muller, 1993, Effects of purinergic agents on human mononuclear phagocytes are differentiation dependentα Implications for atherogenesis, Arterioscler. Thromb. Vasc. Biol., 13, 1317, 10.1161/01.ATV.13.9.1317 Stohr, 1998, Enhanced upregulation of the Fc gamma receptor IIIa (CD16a) during in vitro differentiation of apoE4/E4 monocytes, Arterioscler. Thromb. Vasc. Biol., 18, 1424, 10.1161/01.ATV.18.9.1424 Bhakdi, 1999, Complement and atherosclerosis: binding of CRP to degraded, nonoxidized LDL enhances complement activation, Arterioscler. Thromb. Vasc. Biol., 19, 2348, 10.1161/01.ATV.19.10.2348 Suriyaphol, 2002, Enzymatically modified nonoxidized low-density lipoprotein induces interleukin-8 in human endothelial cells, Circulation, 106, 2581, 10.1161/01.CIR.0000038366.11851.D0 Wieland, 1993, Peroxidase-dependent metal-independent oxidation of low density lipoprotein in vitro: a model for in vivo oxidation?, Proc. Natl. Acad. Sci. U. S. A., 90, 5929, 10.1073/pnas.90.13.5929 Schmitz, 1984, A quantitative densitometric method for the rapid separation and quantitation of the major tissue and lipoprotein lipids by high performance thin-layer chromatography, and densitometry, J. Chromatogr., 307, 65, 10.1016/S0378-4347(00)84073-6 Schmitz, 1984, A quantitative densitometric method for the rapid separation and quantitation of the major tissue and lipoprotein lipids by high performance thin-layer chromatography. II. Reduction of the densitometric data, J. Chromatogr., 307, 81, 10.1016/S0378-4347(00)84074-8 Liebisch, 2006, High throughput quantification of cholesterol and cholesteryl ester by electrospray ionization tandem mass spectrometry(ESI-MS/MS), Biochem. Biophys. Acta, 1762, 121 Pitas, 1981, Acetoacetylated lipoproteins used to distinguish fibroblasts from macrophages in vitro by fluorescence microscopy, Arteriosclerosis, 1, 177, 10.1161/01.ATV.1.3.177 Rothe, 1996, Peripheral blood mononuclear phagocyte subpopulations as cellular markers in hypercholesterolemia, Arterioscler. Thromb. Vasc. Biol., 16, 1437, 10.1161/01.ATV.16.12.1437 Allen, 1992, Flow cytometry analysis of the expression of neutrophil FMLP receptors, J. Immunol. Methods, 149, 159, 10.1016/0022-1759(92)90246-P Kivipelto, 2001, Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study, BMJ, 322, 1447, 10.1136/bmj.322.7300.1447 Ehehalt, 2003, Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts, J. Cell Biol., 160, 113, 10.1083/jcb.200207113 Yanagisawa, 2002, Cholesterol-dependent aggregation of amyloid β-protein, Ann. N.Y. Acad. Sci., 977, 384, 10.1111/j.1749-6632.2002.tb04841.x Subasinghe, 2003, Cholesterol is necessary both for toxic effect of Aβ peptides on vascular smooth muscle cells and Aβ binding to the vascular smooth muscle cell membranes, J. Neurochem., 84, 471, 10.1046/j.1471-4159.2003.01552.x Miller, 2004, The role of cholesterol and statins in Alzheimer's disease, Ann. Pharmacother., 38, 91, 10.1345/aph.1D104 Winblad, 2007, Effects of statins on cognitive function in patients with Alzheimer's disease in galantamine clinical trials, Drugs Aging, 24, 57, 10.2165/00002512-200724010-00004 Zhou, 2007, Prevention and treatment of dementia or Alzheimer's disease by statins: a meta-analysis, Dement. Geriatr. Cogn. Disord., 23, 194, 10.1159/000099037 Reitz, 2004, Relation of plasma lipids to Alzheimer disease and vascular dementia, Arch. Neurol., 61, 705, 10.1001/archneur.61.5.705 Kapinsky, 2001, Enzymatically degraded LDL preferentially binds to CD14high CD16+ monocytes and induces foam cell formation mediated only in part by the class B scavenger-receptor CD36, Arterioscler. Thromb. Vasc. Biol., 21, 1004, 10.1161/01.ATV.21.6.1004 Kellner-Weibel, 1998, Effects of intracellular free cholesterol accumulation on macrophage viability: a model for foam cell death, Arterioscler. Thromb. Vasc. Biol., 18, 423, 10.1161/01.ATV.18.3.423 Jialal, 1989, Differences in the metabolism of oxidatively modified low density lipoprotein and acetylated low density lipoprotein by human endothelial cells: inhibition of cholesterol esterification by oxidatively modified low density lipoprotein, J. Lipid Res., 30, 1561, 10.1016/S0022-2275(20)38240-7 Brown, 2000, Cholesterol and oxysterol metabolism and subcellular distribution in macrophage foam cells. Accumulation of oxidized esters in lysosomes, J. Lipid Res., 41, 226, 10.1016/S0022-2275(20)32056-3 Nägga, 2002, Cerebrospinal fluid phospho-tau, total tau and β-amyloid1–42 in the differentiation between Alzheimer's disease and vascular dementia, Dement. Geriatr. Cogn. Disord., 14, 183, 10.1159/000066023 Fujiwara, 2003, Relationships between plasma β-amyloid1–42 and atherosclerotic risk factors in community-based older populations, Gerontology, 49, 374, 10.1159/000073765 Sjögren, 2006, Cholesterol and Alzheimer's disease — is there a relation?, Mech. Ageing Dev., 127, 138, 10.1016/j.mad.2005.09.020 Casoli, 2007, Release of beta-amyloid from high-density platelets: implications for Alzheimer's disease pathology, Ann. N.Y. Acad. Sci., 1096, 170, 10.1196/annals.1397.082 Li, 1998, Secretion of Alzheimer's disease Aβ amyloid peptide by activated human platelets, Lab. Invest., 78, 461 Smith, 2001, Platelet Secretion of β-amyloid is Increased in Hypercholesterolaemia, Brain Res., 896, 161, 10.1016/S0006-8993(01)02080-7